Table 1. Characteristics of patients who underwent potentially curative resection for ductal adenocarcinoma of the head of the pancreas: univariate survival analysis.
| Patients (n=65) | HR (95% CI) | P-value | |
|---|---|---|---|
| Age (<65/>65 years) | 37/28 | 0.66 (0.39–1.12) | 0.127 |
| Sex (f/m) | 33/32 | 1.78 (1.06–2.99) | 0.031 |
| Stage (I/II/III) | 17/2/46 | 1.13 (0.83–1.53) | 0.449 |
| Resection margin R0/R1 | 19/46 | 1.64 (0.92–2.91) | 0.094 |
| Tumour size (⩽25/>25 mm) | 27/38 | 1.99 (1.14–3.45) | 0.015 |
| Lymph node invasion (−/+) | 20/45 | 1.25 (0.71–2.22) | 0.444 |
| Perineural invasion (−/+) | 6/59 | 1.01 (0.44–2.37) | 0.973 |
| Vascular invasion (−/+) | 39/26 | 2.75 (1.60–4.71) | <0.001 |
| Tumour differentiation (well/moderate/poor) | 8/36/21 | 1.46 (0.97–2.20) | 0.072 |
| Albumin (⩾35/<35 g l−1) | 40/25 | 1.00 (0.59–1.71) | 0.987 |
| Bilirubin (⩽22/>22 μmol l−1) | 12/53 | 1.12 (0.56–2.23) | 0.750 |
| Biliary stent (no/yes) | 32/33 | 1.06 (0.63–1.76) | 0.836 |
| Preoperative | |||
| C-reactive protein (⩽10/>10 mg l−1) | 32/33 | 2.56 (1.51–4.36) | <0.001 |
| Postoperative | |||
| C-reactive protein (⩽10/>10 mg l−1) | 33/32 | 2.50 (1.46–4.29) | <0.001 |
CI=confidence interval; HR=hazard ratio.